1163TiP - Activity and Safety of Everolimus in Combination with Octreotide Lar and Metformin in Patients with Advanced Pancreatic Well-Differentiated Neuroendocrine Tumors (Pwdnets): a Single–Center, Open-Label, Phase Ii, Proof-Of-Concept Study (Metnet1 Trial)
| Autor: | De Braud, F.G.M., Pusceddu, S., Formisano, B., Consonni, P., Pacifici, M., Pulice, J., Concas, L., Festinese, F., Bregant, C., Martinetti, A., Buzzoni, R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv405-iv405 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|